Compounds > mifepristone
Page last updated: 2024-08-23

mifepristone and Experimental Neoplasms

mifepristone has been researched along with Experimental Neoplasms in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (12.50)18.2507
2000's4 (50.00)29.6817
2010's2 (25.00)24.3611
2020's1 (12.50)2.80

Authors

AuthorsStudies
Chen, C; Chen, H; Gao, Y; Huang, J; Lin, Y; Liu, R; Liu, S; Ye, J; Zhang, Y; Zhao, P; Zheng, Z; Zhou, J1
Bast, RC; Cheon, DJ; Cho, CH; Coffey, DM; DeMayo, FJ; Emerson, RE; Fernández, FM; Godwin, AK; Hawkins, SM; Karpf, AR; Kim, J; Kim, O; Kwon, SY; Lydon, JP; Miller, KD; Nephew, KP; Park, EY; Quilliam, LA; Shin, S; Shin, YH; Sood, AK; Widschwendter, M1
Chen, J; Fang, GE; Liu, XS; Qian, QJ; Su, CQ; Wang, F; Xue, XC1
Le, W; Li, T; Song, L; Wang, Y; Yang, D; Yang, J; Zhang, X1
Deng, Y; Liu, Y; Wang, LL1
Bali, M; Gandhi, S; Li, Z; Masih-Khan, E; Pollett, JB; Stewart, AK; Wen, XY; Zhu, YX1
Brouckaert, P; Everaerdt, B; Fiers, W1
DeMayo, FJ; Matzuk, MM; Omalley, BW; Pierson, TM; Tsai, SY; Wang, Y1

Other Studies

8 other study(ies) available for mifepristone and Experimental Neoplasms

ArticleYear
Discovery of novel mifepristone derivatives via suppressing KLF5 expression for the treatment of triple-negative breast cancer.
    European journal of medicinal chemistry, 2018, Feb-25, Volume: 146

    Topics: Administration, Oral; Animals; Antineoplastic Agents; Cell Cycle; Cell Proliferation; Dose-Response Relationship, Drug; Drug Discovery; Drug Screening Assays, Antitumor; Female; Humans; Kruppel-Like Transcription Factors; Male; Mice; Mice, Inbred BALB C; Mice, Inbred Strains; Mice, Nude; Mifepristone; Molecular Structure; Neoplasms, Experimental; Rats; Rats, Sprague-Dawley; Structure-Activity Relationship; Tumor Cells, Cultured

2018
Targeting progesterone signaling prevents metastatic ovarian cancer.
    Proceedings of the National Academy of Sciences of the United States of America, 2020, 12-15, Volume: 117, Issue:50

    Topics: Adult; Animals; BRCA1 Protein; Breast; Breast Neoplasms; Cystadenocarcinoma, Serous; Disease Models, Animal; Estradiol; Female; Humans; Mice; Middle Aged; Mifepristone; Mutation; Neoplasms, Experimental; Ovarian Neoplasms; Ovary; Progesterone; Receptors, Progesterone; Salpingo-oophorectomy; Signal Transduction

2020
[Construction of a RU486 inducible recombinant adenoviral vector carrying murine interleukin-12 gene and experimental treatment of colonic carcinoma].
    Zhonghua yi xue za zhi, 2009, May-26, Volume: 89, Issue:20

    Topics: Adenoviridae; Animals; Cell Line, Tumor; Colonic Neoplasms; Female; Gene Transfer Techniques; Genetic Therapy; Genetic Vectors; Interleukin-12; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Mifepristone; Neoplasms, Experimental; Recombinant Fusion Proteins; Transduction, Genetic; Transfection

2009
Mifepristone-inducible caspase-1 expression in mouse embryonic stem cells eliminates tumor formation but spares differentiated cells in vitro and in vivo.
    Stem cells (Dayton, Ohio), 2012, Volume: 30, Issue:2

    Topics: Animals; Antineoplastic Agents; Caspase 1; Cell Death; Cell Survival; Dopaminergic Neurons; Embryonic Stem Cells; Enzyme Activation; Enzyme Activators; Female; Gene Expression Regulation; Genes, Reporter; Green Fluorescent Proteins; Male; Mice; Mice, Nude; Mifepristone; Neoplasms, Experimental; Parkinson Disease; Regenerative Medicine; Teratoma; Tumor Burden

2012
Enhancement of antitumor effect of cisplatin against human ovarian carcinoma cells by mifepristone in vivo.
    Di 1 jun yi da xue xue bao = Academic journal of the first medical college of PLA, 2003, Volume: 23, Issue:3

    Topics: Abortifacient Agents, Steroidal; Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Division; Cisplatin; Disease Models, Animal; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Drug Synergism; Female; Humans; Mice; Mice, Nude; Mifepristone; Neoplasm Transplantation; Neoplasms, Experimental; Ovarian Neoplasms; Tumor Cells, Cultured; Xenograft Model Antitumor Assays

2003
RU486-inducible retrovirus-mediated caspase-3 overexpression is cytotoxic to bcl-xL-expressing myeloma cells in vitro and in vivo.
    Molecular therapy : the journal of the American Society of Gene Therapy, 2003, Volume: 8, Issue:2

    Topics: Animals; Apoptosis; bcl-X Protein; Caspase 3; Caspases; Cell Line, Tumor; Enzyme Induction; Genetic Therapy; Genetic Vectors; Humans; Mice; Mifepristone; Multiple Myeloma; Neoplasms, Experimental; NIH 3T3 Cells; Protein-Tyrosine Kinases; Proto-Oncogene Proteins c-bcl-2; Receptor, Fibroblast Growth Factor, Type 3; Receptors, Fibroblast Growth Factor; Retroviridae; Survival Rate; Time Factors

2003
Recombinant IL-1 receptor antagonist protects against TNF-induced lethality in mice.
    Journal of immunology (Baltimore, Md. : 1950), 1994, May-15, Volume: 152, Issue:10

    Topics: Animals; Body Temperature; Female; Interleukin 1 Receptor Antagonist Protein; Interleukin-1; Interleukin-6; Male; Mice; Mice, Inbred C57BL; Mifepristone; Neoplasms, Experimental; Receptors, Interleukin-1; Recombinant Proteins; Sialoglycoproteins; Tumor Necrosis Factor-alpha

1994
Regulable expression of inhibin A in wild-type and inhibin alpha null mice.
    Molecular endocrinology (Baltimore, Md.), 2000, Volume: 14, Issue:7

    Topics: Animals; Cell Line; Female; Follicle Stimulating Hormone; Genetic Engineering; Inhibins; Liver; Male; Mice; Mice, Knockout; Mice, Mutant Strains; Mifepristone; Neoplasms, Experimental; Ovary; Peptides; Pituitary Gland; Promoter Regions, Genetic; Testicular Neoplasms; Testis

2000